-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Qzb6eWtW7uHD7yFQu2PO4U/hmjDd2eygYcsEufyC07ozMMIWeNTng4VDkCxKMSqs vipNsORJ/lfZcP2DftNRbw== 0000875320-07-000019.txt : 20070201 0000875320-07-000019.hdr.sgml : 20070201 20070201124258 ACCESSION NUMBER: 0000875320-07-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070131 FILED AS OF DATE: 20070201 DATE AS OF CHANGE: 20070201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALAM JOHN J CENTRAL INDEX KEY: 0001197014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 07570828 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-01-31 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197014 ALAM JOHN J C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 01239 0 1 0 0 EVP, Medicines Dev., & CMO Common Stock 2007-01-31 4 M 0 1000 18.47 A 136460 D Common Stock 2007-01-31 4 M 0 500 9.07 A 136960 D Common Stock 2007-01-31 4 S 0 1000 35.46 D 135960 D Common Stock 2007-01-31 4 S 0 500 35.46 D 135460 D Common Stock 6265 I 401(k) Stock Options 18.47 2007-01-31 4 M 0 1000 0 D 2007-09-25 Common Stock 1000 1966 D Stock Options 9.07 2007-01-31 4 M 0 500 0 D 2004-03-11 2013-12-10 Common Stock 500 9400 D Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1. Fully exercisable. Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003. Valerie L. Andrews, Attorney-In-Fact 2007-02-01 -----END PRIVACY-ENHANCED MESSAGE-----